SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:954f2854-6598-4f2d-94ad-7aef449a66b7"
 

Search: onr:"swepub:oai:lup.lub.lu.se:954f2854-6598-4f2d-94ad-7aef449a66b7" > International Myelo...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Dispenzieri, A. (author)

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

  • Article/chapterEnglish2009

Publisher, publication year, extent ...

  • 2008-11-20
  • Springer Science and Business Media LLC,2009

Numbers

  • LIBRIS-ID:oai:lup.lub.lu.se:954f2854-6598-4f2d-94ad-7aef449a66b7
  • https://lup.lub.lu.se/record/1374876URI
  • https://doi.org/10.1038/leu.2008.307DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:118289370URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:for swepub-publicationtype
  • Subject category:ref swepub-contenttype

Notes

  • The serum immunoglobulin-free light chain (FLC) assay measures levels of free kappa and lambda immunoglobulin light chains. There are three major indications for the FLC assay in the evaluation and management of multiple myeloma and related plasma cell disorders (PCD). In the context of screening, the serum FLC assay in combination with serum protein electrophoresis (PEL) and immunofixation yields high sensitivity, and negates the need for 24-h urine studies for diagnoses other than light chain amyloidosis (AL). Second, the baseline FLC measurement is of major prognostic value in virtually every PCD. Third, the FLC assay allows for quantitative monitoring of patients with oligosecretory PCD, including AL, oligosecretory myeloma and nearly two-thirds of patients who had previously been deemed to have non-secretory myeloma. In AL patients, serial FLC measurements outperform PEL and immunofixation. In oligosecretory myeloma patients, although not formally validated, serial FLC measurements reduce the need for frequent bone marrow biopsies. In contrast, there are no data to support using FLC assay in place of 24-h urine PEL for monitoring or for serial measurements in PCD with measurable disease by serum or urine PEL. This paper provides consensus guidelines for the use of this important assay, in the diagnosis and management of clonal PCD.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Kyle, R. (author)
  • Merlini, G. (author)
  • Miguel, J. S. (author)
  • Ludwig, H. (author)
  • Hajek, R. (author)
  • Palumbo, A. (author)
  • Jagannath, S. (author)
  • Blade, J. (author)
  • Lonial, S. (author)
  • Dimopoulos, M. (author)
  • Comenzo, R. (author)
  • Einsele, H. (author)
  • Barlogie, B. (author)
  • Anderson, K. (author)
  • Gertz, M. (author)
  • Harousseau, J. L. (author)
  • Attal, M. (author)
  • Tosi, P. (author)
  • Sonneveld, P. (author)
  • Boccadoro, M. (author)
  • Morgan, G. (author)
  • Richardson, P. (author)
  • Sezer, O. (author)
  • Mateos, M. V. (author)
  • Cavo, M. (author)
  • Joshua, D. (author)
  • Turesson, IngemarLund University,Lunds universitet,Institutionen för kliniska vetenskaper, Malmö,Medicinska fakulteten,Department of Clinical Sciences, Malmö,Faculty of Medicine(Swepub:lu)medf-itu (author)
  • Chen, W. (author)
  • Shimizu, K. (author)
  • Powles, R. (author)
  • Rajkumar, S. V. (author)
  • Durie, B. G. M. (author)
  • Institutionen för kliniska vetenskaper, MalmöMedicinska fakulteten (creator_code:org_t)

Related titles

  • In:Leukemia: Springer Science and Business Media LLC23:2, s. 215-2241476-55510887-6924

Internet link

Find in a library

  • Leukemia (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view